Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001656-21Phase 2Completed
Phase 2, randomised, double-blind trial of axomadol in postoperative pain (5 arms), sponsored by Grünenthal GmbH. Primary endpoint: Time-averaged pain intensity while swallowing on Days 4 and 5 (TAPI-48). Started Jun 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001656-21.